Sale!

EGR2 Gene Dejerine-Sottas Disease Genetic Test

Original price was: $700.Current price is: $500.

-29%

The EGR2 Gene Dejerine-Sottas Disease NGS Genetic DNA Test is a comprehensive genetic analysis designed to detect mutations in the EGR2 gene associated with Dejerine-Sottas disease, a severe form of hereditary motor and sensory neuropathy. This advanced next-generation sequencing test provides crucial diagnostic information for individuals experiencing progressive muscle weakness, sensory loss, and neurological symptoms. The test helps identify specific genetic variants that cause this inherited peripheral neuropathy, enabling early intervention and personalized treatment planning. At only $500 USD, this test offers accessible genetic screening with results available within 3-4 weeks. Our testing process includes genetic counseling and requires clinical history documentation for optimal accuracy.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

EGR2 Gene Dejerine-Sottas Disease NGS Genetic DNA Test

Comprehensive Genetic Testing for Hereditary Neuropathy

The EGR2 Gene Dejerine-Sottas Disease NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations responsible for Dejerine-Sottas disease, a severe form of hereditary motor and sensory neuropathy type III. This neurological condition affects the peripheral nervous system, leading to progressive muscle weakness, sensory impairment, and significant mobility challenges. Our advanced genetic testing utilizes next-generation sequencing technology to provide comprehensive analysis of the EGR2 gene, offering patients and healthcare providers critical insights for accurate diagnosis and personalized treatment strategies.

What Does This Test Measure and Detect?

This specialized genetic test focuses on identifying mutations within the EGR2 (Early Growth Response 2) gene, which plays a crucial role in the development and maintenance of peripheral nerves. The test specifically detects:

  • Point mutations, deletions, and insertions in the EGR2 gene
  • Genetic variants associated with Dejerine-Sottas disease inheritance patterns
  • Mutations affecting myelin sheath formation and nerve conduction
  • Specific genetic markers linked to disease severity and progression

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

This test is recommended for individuals experiencing symptoms consistent with hereditary neuropathies, including:

  • Progressive muscle weakness beginning in early childhood
  • Delayed motor milestones and walking difficulties
  • Sensory loss in extremities
  • Foot deformities such as pes cavus (high arches)
  • Reduced or absent deep tendon reflexes
  • Family history of similar neurological conditions
  • Unexplained peripheral neuropathy in childhood

Benefits of EGR2 Genetic Testing

Undergoing the EGR2 Gene Dejerine-Sottas Disease NGS Genetic DNA Test provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out genetic causes of peripheral neuropathy
  • Early Intervention: Enables timely management and treatment planning
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Personalized Care: Guides targeted therapeutic approaches based on genetic findings
  • Prognostic Information: Helps predict disease progression and potential complications

Understanding Your Test Results

Our comprehensive genetic analysis provides detailed insights into your EGR2 gene status:

  • Positive Result: Indicates the presence of a pathogenic mutation associated with Dejerine-Sottas disease, confirming the genetic diagnosis
  • Negative Result: Suggests no detectable mutations in the EGR2 gene, though other genetic or acquired causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation

All results are accompanied by detailed interpretation from our certified genetic counselors and neurologists, ensuring you receive comprehensive guidance for next steps.

Test Details and Pricing

Test Component Details
Test Name EGR2 Gene Dejerine-Sottas Disease NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Specialty Neurology
Department Genetics
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure optimal testing accuracy, we require:

  • Complete clinical history of the patient
  • Genetic counseling session with our certified specialists
  • Detailed pedigree chart documenting family members affected by similar neurological conditions
  • Informed consent for genetic testing

Nationwide Testing Availability

We proudly offer the EGR2 Gene Dejerine-Sottas Disease NGS Genetic DNA Test across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee. Our extensive network ensures accessible genetic testing services for patients nationwide.

Take Control of Your Neurological Health Today

Don’t let uncertainty about hereditary neuropathy affect your quality of life. Our EGR2 Gene Dejerine-Sottas Disease NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With our discounted price of only $500 USD and comprehensive genetic counseling support, you can access world-class neurological genetic testing.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our expert team is ready to guide you through every step of the testing process and help you understand your genetic health.